4 completed, 2 unknown, 1 terminated, 1 withdrawn. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 4, Unknown 2, Terminated 1, Withdrawn 1 |
Follow Stalevo: new trials by email Literature Review of Stalevo trials Research Report on Stalevo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease levodopa/carbidopa/entacapone - Parkinson Disease | Phase 4 | Unknown | Second Affiliated Hospital of Soochow University | 60 | 2023-11-15 | 2024-02-01 |
| Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease Stalevo, Carbidopa and Levodopa Controlled Release Tablets - Parkinson Disease | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 180 | 2022-01-01 | 2023-02-16 |
| Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off carbidopa/levodopa, Carbidopa/Levodopa/Entacapone - Parkinson's Disease | Phase 4 | Withdrawn | Novartis Pharmaceuticals | 2008-08-01 | 2012-04-30 | |
| Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off Carbidopa/levodopa/entacapone, Immediate release carbidopa/levodopa - Parkinson's Disease | Phase 4 | Terminated | Novartis | 14 | 2008-03-01 | 2011-02-18 |
| Study to Evaluate Initiation of Stalevo in Early Wearing-off Stalevo - Parkinson's Disease | Phase 4 | Completed | Orion Corporation, Orion Pharma | 115 | 2006-09-01 | 2015-04-21 |
| Stalevo in Early Wearing-Off Patients Stalevo (levodopa/carbidopa/entacapone), Levodopa/carbidopa - Idiopathic Parkinson's Disease | Phase 4 | Completed | Orion Corporation, Orion Pharma | 223 | 2005-08-01 | 2009-06-22 |
| Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States carbidopa, levodopa, entacapone - Parkinson's Disease | Phase 4 | Completed | Novartis | 184 | 2005-07-01 | 2017-03-29 |
| Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease Carbidopa/levodopa/entacapone - Parkinson's Disease With End of Dose Wearing Off | Phase 4 | Completed | Novartis Pharmaceuticals | 359 | 2005-01-01 | 2017-03-30 |
Parkinson Disease (8) · Tremor (1)
Novartis (2) · Novartis Pharmaceuticals (2) · Orion Corporation, Orion Pharma (2) · Second Affiliated Hospital of Soochow University (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1)
China (2) · Germany (2) · Sweden (2) · United Kingdom (2) · United States (2) · Australia (1) · Denmark (1) · Finland (1) · Ireland (1) · Philippines (1) · Puerto Rico (1) · Taiwan (1) · Thailand (1)
Andrew Wighton, BSc (Hons) (1) · Bhadravati SD Sastry, FRCP (1) · Chun-Feng Liu, MD,PhD (1) · Wolfgang H. Oertel, Professor (1)